Relmada Therapeutics, Inc. Common Stock (RLMD)
Relmada Therapeutics, Inc. Common Stock (RLMD) has a 13-report earnings history dating back to Mar 23, 2022. Its average absolute post-earnings move is ±5.00%, and 46.2% of those reactions were positive. Its largest post-earnings gain was +8.55% (Nov 10, 2022) and its largest decline was -18.11% (Mar 19, 2024).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
13
Avg Abs. Movement
±5.00%
Positive %
46.2%
Negative %
53.8%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ☽ POST | $7.31 | $7.48 | $7.45 | 119,667 | +0.67% | open_in_new |
| Mar 20, 2026 | ☽ POST | $6.32 | $6.64 | $6.05 | 41,539 | -3.47% | open_in_new |
| Nov 13, 2025 | ☽ POST | $3.83 | $4.19 | $3.89 | 75,746 | +1.8% | open_in_new |
| Aug 07, 2025 | ☽ POST | $0.57 | $0.57 | $0.57 | 0 | +0% | open_in_new |
| Mar 27, 2025 | ☽ POST | $0.30 | $0.30 | $0.30 | 1,850 | -1.46% | open_in_new |
| Mar 19, 2024 | ☽ POST | $5.58 | $5.77 | $5.41 | 32,205 | -18.11% | open_in_new |
| Nov 08, 2023 | ☽ POST | $2.99 | $3.08 | $3.08 | 4,483 | -2.92% | open_in_new |
| Aug 08, 2023 | ☽ POST | $2.65 | $2.71 | $2.54 | 3,730 | +7.07% | open_in_new |
| May 11, 2023 | ☽ POST | $3.43 | $3.43 | $3.19 | 1,512 | -6.9% | open_in_new |
| Mar 23, 2023 | ☽ POST | $2.47 | $2.47 | $2.31 | 4,891 | -1.74% | open_in_new |
| Nov 10, 2022 | ☽ POST | $5.88 | $6.02 | $5.85 | 41,760 | +8.55% | open_in_new |
| May 05, 2022 | ☽ POST | $23.32 | $23.38 | $22.30 | 22,748 | -4.95% | open_in_new |
| Mar 23, 2022 | ☽ POST | $23.24 | $24.01 | $23.34 | 11,332 | +7.37% | open_in_new |
Earnings Count
13
Total earnings in dataset
Avg Abs. Movement
±5.00%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
4 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| SCHEDULE 13G | 20260609 | open_in_new SEC.gov |
| 8-K | 20260528 | open_in_new SEC.gov |
| S-3ASR | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
Frequently asked about RLMD earnings
How much does RLMD stock move after earnings? expand_more
Over 13 reports, RLMD has moved an average of ±5.00% the session after earnings, closing higher 46.2% of the time.
What was RLMD's biggest post-earnings move? expand_more
RLMD's largest post-earnings gain on record was +8.55% on Nov 10, 2022, and its largest decline was -18.11% on Mar 19, 2024.
Where can I find Relmada Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Relmada Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right